Glaxo onboards promotional doctors

Share this article:

GlaxoSmithKline made a bit of a wave when it announced in December that it would no longer pay doctors to promote its drugs or to attend medical conferences.

Now comes part two: While Glaxo will not pay external doctors to talk up its drugs, it will hire doctor employees who will then go out into the field to discuss the company's drugs, reports Bloomberg.

Bloomberg reports that the new strategy will result in fewer doctors talking on GSK's behalf, and that this new crew has an added benefit: no need to report these payments under the Sunshine Act because these physicians work for GSK and are not presented as a disinterested party. Bloomberg posits this may knock GSK PhDs into being equated with medical science liaisons because these doctors will not be able to offer medical advice and are not practicing physicians.

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Business Briefs

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Business Briefs

Novartis said to be stepping out of HCV

Novartis is said to have relinquished rights to an investigational hep. C treatment, signaling its exit from the therapeutic space, according to a former partner's announcement.

Monday Moves: September 15

Hires and promotions for manufacturers, regulatory and agencies

Kantar acquires Evidências, expands Brazilian presence

The company's acquisition signals the growing importance of understanding the Brazilian healthcare market and evidence-based healthcare management services.